Chemical and Pharmaceutical Bulletin · 2010 · 56 citations · 13 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsAnti-inflammatory PharmacologyHit-to-lead OptimizationInflammation PharmacologyLead Compound DesignLead DiscoveryStructure-activity Relationship AnalysisAnti-inflammatory ActivityAnti-inflammatory Drug DiscoveryAnti-inflammatory ResponseCatalytic Site ArchitectureCyclooxygenase InhibitorsMedicinal Chemistry ApplicationsPyrazole ChemistryPyrazole Synthesis
Series of pyrazole ester prodrugs analogues have been synthesized and found to contain highly potent inhibitors of the cyclooxygenase-2 (COX-2) enzyme. The paper describes synthesis of the target pyrazole analogues. The structure of the synthesized mutual ester prodrugs (6-8c) were confirmed by (1)H-, (13)C-NMR mass spectroscopy (MS) and their purity were ascertained by TLC and elemental analyses. The biological in vivo evaluation of these compounds in experimental models (carrageenan-induced oedema) proved the presence of anti-inflammatory activity. Docking studies into the catalytic site of COX-2 were used to identify potential anti-inflammatory lead compounds. One lead derivative was chosen endowed with good binding energies.
13
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents
Ravi G. Kurumbail, Anna M. Stevens, James K. Gierse et al. · Nature · 1996 · 1.9K citations
Timothy Hla, Karen M. Neilson · Proceedings of the National Academy of Sciences · 1992 · 1.5K citations